Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms

Imagem de Miniatura
Arquivos
art_CURY_Sensory_abnormalities_and_pain_in_Parkinson_disease_and_2016.PDF (529.7 KB)
Citações na Scopus
67
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
LLORET, S. Perez
Citação
EUROPEAN JOURNAL OF PAIN, v.20, n.2, p.151-165, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Pain and sensory abnormalities are present in a large proportion of Parkinson disease (PD) patients and have a significant negative impact in quality of life. It remains undetermined whether pain occurs secondary to motor impairment and to which extent it can be relieved by improvement of motor symptoms. The aim of this review was to examine the current knowledge on the mechanisms behind sensory changes and pain in PD and to assess the modulatory effects of motor treatment on these sensory abnormalities. A comprehensive literature search was performed. We selected studies investigating sensory changes and pain in PD and the effects of levodopa administration and deep brain stimulation (DBS) on these symptoms. PD patients have altered sensory and pain thresholds in the off-medication state. Both levodopa and DBS improve motor symptoms (i.e.: bradykinesia, tremor) and change sensory abnormalities towards normal levels. However, there is no direct correlation between sensory/pain changes and motor improvement, suggesting that motor and non-motor symptoms do not necessarily share the same mechanisms. Whether dopamine and DBS have a real antinociceptive effect or simply a modulatory effect in pain perception remain uncertain. These data may provide useful insights into a mechanism-based approach to pain in PD, pointing out the role of the dopaminergic system in pain perception and the importance of the characterization of different pain syndromes related to PD before specific treatment can be instituted.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/13455
Referências
  1. Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629
  2. Nandhagopal R, 2010, PAIN MED, V11, P834, DOI 10.1111/j.1526-4637.2010.00866.x
  3. Tolosa E, 2007, PARKINSONISM RELAT D, V13, pS2, DOI 10.1016/j.parkreldis.2007.06.007
  4. Tinazzi M, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.079053
  5. Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008
  6. Lopez-Avila A, 2004, PAIN, V111, P136, DOI 10.1016/j.pain.2004.06.010
  7. Slaoui T, 2007, REV NEUROL-FRANCE, V163, P66, DOI 10.1016/S0035-3787(07)90356-2
  8. Hilker R, 2004, J CEREBR BLOOD F MET, V24, P7, DOI 10.1097/01.WCB.0000092831.44769.09
  9. Djaldetti R, 2007, CLIN NEUROPHARMACOL, V30, P201, DOI 10.1097/WNF.0B013E3180340319
  10. Ray NJ, 2008, EXP NEUROL, V213, P108, DOI 10.1016/j.expneurol.2008.05.008
  11. Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005
  12. Ford B, 1998, CLIN NEUROSCI, V5, P63
  13. Spielberger S, 2011, MOVEMENT DISORD, V26, P1367, DOI 10.1002/mds.23570
  14. Loher TJ, 2002, J NEUROL NEUROSUR PS, V73, P395, DOI 10.1136/jnnp.73.4.395
  15. JENSEN TS, 1982, EUR J PHARMACOL, V79, P129, DOI 10.1016/0014-2999(82)90584-2
  16. Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59
  17. Tashev R, 2001, PEPTIDES, V22, P1079, DOI 10.1016/S0196-9781(01)00431-4
  18. Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007
  19. Pertovaara A, 2004, EUR J NEUROSCI, V20, P1587, DOI 10.1111/j.1460-9568.2004.03622.x
  20. Mylius V, 2009, J NEUROL NEUROSUR PS, V80, P24, DOI 10.1136/jnnp.2008.145995
  21. BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X
  22. Schultz W, 1998, J NEUROPHYSIOL, V80, P1
  23. Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009
  24. DICHIARA G, 1988, J PHARMACOL EXP THER, V244, P1067
  25. Hagelberg N, 2002, PAIN, V99, P273, DOI 10.1016/S0304-3959(02)00121-5
  26. Marques A, 2013, NEUROLOGY, V81, P633, DOI 10.1212/WNL.0b013e3182a08d00
  27. Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106
  28. Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275
  29. BENSRETI MM, 1983, LIFE SCI, V33, P665, DOI 10.1016/0024-3205(83)90590-8
  30. Prodoehl J, 2008, J NEUROPHYSIOL, V99, P3042, DOI 10.1152/jn.01108.2007
  31. Dellapina E, 2011, MOVEMENT DISORD, V26, P153, DOI 10.1002/mds.23406
  32. Picarelli H, 2010, J PAIN, V11, P1203, DOI 10.1016/j.jpain.2010.02.006
  33. Beiske AG, 2009, PAIN, V141, P173, DOI 10.1016/j.pain.2008.12.004
  34. Honey CR, 1999, J NEUROSURG, V91, P198, DOI 10.3171/jns.1999.91.2.0198
  35. Schestatsky P, 2007, NEUROLOGY, V69, P2162, DOI 10.1212/01.wnl.0000295669.12443.d3
  36. Coffeen U, 2008, EUR J PAIN, V12, P535, DOI 10.1016/j.ejpain.2007.08.008
  37. Kim HJ, 2012, NEUROSURGERY, V70, P18, DOI 10.1227/NEU.0b013e3182266664
  38. Negre-Pages L, 2008, MOVEMENT DISORD, V23, P1361, DOI 10.1002/mds.22142
  39. LAITINEN LV, 1992, J NEUROSURG, V76, P53, DOI 10.3171/jns.1992.76.1.0053
  40. BAEV KV, 1995, NEUROL RES, V17, P38
  41. Djaldetti R, 2004, NEUROLOGY, V62, P2171
  42. Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013
  43. Dellapina E, 2012, PAIN, V153, P2267, DOI 10.1016/j.pain.2012.07.026
  44. Conte A, 2013, NAT REV NEUROL, V9, P687, DOI 10.1038/nrneurol.2013.224
  45. Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015
  46. Chudler EH, 1998, BRAIN RES, V812, P283, DOI 10.1016/S0006-8993(98)00971-8
  47. LEONE P, 1991, PHARMACOL BIOCHEM BE, V39, P469, DOI 10.1016/0091-3057(91)90210-S
  48. SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046
  49. Altier N, 1998, J PHARMACOL EXP THER, V285, P208
  50. Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x
  51. Markus Z, 2008, ACTA BIOL HUNG, V59, P269, DOI 10.1556/ABiol.59.2008.3.1
  52. Reichling DB, 2011, ANN NEUROL, V69, P13, DOI 10.1002/ana.22351
  53. Kanda T, 1996, ACTA NEUROPATHOL, V91, P145
  54. Le Jeune F, 2010, EUR J NUCL MED MOL I, V37, P1512, DOI 10.1007/s00259-010-1436-y
  55. Jobst EE, 1997, ARCH NEUROL-CHICAGO, V54, P450
  56. Garcia-Larrea L, 2002, BRAIN, V125, P2766, DOI 10.1093/brain/awf275
  57. Maschke M, 2003, BRAIN, V126, P2312, DOI 10.1093/brain/awg230
  58. Storch A, 2013, NEUROLOGY, V80, P800, DOI 10.1212/WNL.0b013e318285c0ed
  59. Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7
  60. Perrotta A, 2011, MOVEMENT DISORD, V26, P442, DOI [10.1002/mds.23458, 10.1002/23458]
  61. Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006
  62. Ford B, 2009, NAT REV NEUROL, V5, P242, DOI 10.1038/nrneurol.2009.50
  63. Juri C, 2010, J NEUROL SCI, V289, P60, DOI 10.1016/j.jns.2009.08.018
  64. Ford B, 2010, MOVEMENT DISORD, V25, pS98, DOI 10.1002/mds.22716
  65. LIN MT, 1981, J NEURAL TRANSM, V51, P213, DOI 10.1007/BF01248953
  66. Chaudhuri KR, 2010, MOVEMENT DISORD, V25, P704, DOI 10.1002/mds.22868
  67. Porro CA, 1999, EUR J NEUROSCI, V11, P874, DOI 10.1046/j.1460-9568.1999.00494.x
  68. Mongeon D, 2009, NEUROSCIENCE, V158, P426, DOI 10.1016/j.neuroscience.2008.10.013
  69. Altier N, 1999, LIFE SCI, V65, P2269, DOI 10.1016/S0024-3205(99)00298-2
  70. Benazzouz A, 2000, NEUROLOGY, V55, pS13
  71. Li KY, 2010, J NEUROL, V257, P1992, DOI 10.1007/s00415-010-5646-9
  72. Magnusson JE, 2000, BRAIN RES, V855, P260, DOI 10.1016/S0006-8993(99)02396-3
  73. Saade NE, 1997, BRAIN RES, V751, P1, DOI 10.1016/S0006-8993(96)01164-X
  74. SNIDER SR, 1976, NEUROLOGY, V26, P423
  75. Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102
  76. Trost M, 2006, NEUROIMAGE, V31, P301, DOI 10.1016/j.neuroimage.2005.12.024
  77. Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1
  78. Surucu O, 2013, PAIN, V154, P1477, DOI 10.1016/j.pain.2013.03.008
  79. Broen MPG, 2012, MOVEMENT DISORD, V27, P480, DOI 10.1002/mds.24054
  80. Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017
  81. Leyden J, 2008, MED HYPOTHESES, V71, P61, DOI 10.1016/j.mehy.2008.02.013
  82. Wolz M, 2012, PARKINSONISM RELAT D, V18, P994, DOI 10.1016/j.parkreldis.2012.05.011
  83. Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8
  84. Gold A, 2013, MOVEMENT DISORD, V28, P237, DOI 10.1002/mds.25298
  85. CHUDLER EH, 1995, BRAIN RES, V674, P33, DOI 10.1016/0006-8993(94)01427-J
  86. Kim HJ, 2009, J NEUROL SCI, V287, P200, DOI 10.1016/j.jns.2009.07.026
  87. Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324
  88. Maruo T, 2011, PAIN, V152, P860, DOI 10.1016/j.pain.2010.12.038
  89. LEMOAL M, 1991, PHYSIOL REV, V71, P155
  90. CHUDLER EH, 1995, PAIN, V60, P3, DOI 10.1016/0304-3959(94)00172-B
  91. Gerdelat-Mas A, 2007, J NEUROL NEUROSUR PS, V78, P1140, DOI 10.1136/jnnp.2007.120212
  92. Oshima H, 2012, J NEUROSURG, V116, P99, DOI 10.3171/2011.7.JNS11158
  93. Cao H, 2011, AM J NEURORADIOL, V32, P1969, DOI 10.3174/ajnr.A2672
  94. Pellaprat J, 2014, PARKINSONISM RELAT D, V20, P662, DOI 10.1016/j.parkreldis.2014.03.011
  95. SIMON H, 1979, BRAIN RES, V178, P17, DOI 10.1016/0006-8993(79)90085-4
  96. Lim SY, 2008, MOVEMENT DISORD, V23, P1689, DOI 10.1002/mds.22111
  97. Zibetti M, 2007, EUR NEUROL, V58, P218, DOI 10.1159/000107943
  98. Tinazzi M, 2008, PAIN, V136, P117, DOI 10.1016/j.pain.2007.06.022
  99. de Andrade DC, 2012, PAIN, V153, P1107, DOI 10.1016/j.pain.2012.02.016
  100. JENSEN TS, 1984, BRAIN RES, V296, P285, DOI 10.1016/0006-8993(84)90064-7
  101. BATTISTA AF, 1973, ARCH INTERN MED, V132, P70, DOI 10.1001/archinte.132.1.70
  102. LIU QS, 1992, LIFE SCI, V51, P1485
  103. Fasano A, 2012, LANCET NEUROL, V11, P429, DOI 10.1016/S1474-4422(12)70049-2
  104. Witjas T, 2007, MOVEMENT DISORD, V22, P1729, DOI 10.1002/mds.21602
  105. Kim HJ, 2008, J NEUROL, V255, P1889, DOI 10.1007/s00415-009-0908-0
  106. Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
  107. Baron MS, 1996, ANN NEUROL, V40, P355, DOI 10.1002/ana.410400305
  108. Martikainen IK, 2005, NEUROSCI LETT, V376, P149, DOI 10.1016/j.neulet.2004.11.045
  109. Saade NE, 1996, PHYSIOL BEHAV, V60, P559, DOI 10.1016/S0031-9384(96)80032-1
  110. Becker S, 2013, EUR J NEUROSCI, V38, P3080, DOI 10.1111/ejn.12303
  111. Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27
  112. Braak H, 2002, J NEUROL S3, V249, P1, DOI 10.1007/s00415-002-1301-4
  113. Chaudhuri K Ray, 2010, Prog Brain Res, V184, P325, DOI 10.1016/S0079-6123(10)84017-8
  114. Cury RG, 2014, NEUROLOGY, V83, P1403, DOI 10.1212/WNL.0000000000000887
  115. FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335
  116. Gierthmuhlen J, 2010, MOVEMENT DISORD, V25, P1195, DOI 10.1002/mds.23128
  117. Goetz C G, 1986, Mov Disord, V1, P45, DOI 10.1002/mds.870010106
  118. Kassubek J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-42
  119. Park A, 2009, J NEUROL, V256, pS293, DOI 10.1007/s00415-009-5240-1
  120. Quittenbam BH, 2004, PARKINSONISM RELAT D, V10, P129, DOI 10.1016/j.parkreldis.2003.12.001
  121. Scott DJ, 2007, SYNAPSE, V61, P707, DOI 10.1002/syn.20404
  122. Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/26
Artigos e Materiais de Revistas Científicas - LIM/45